Global Gene Editing Technology Market Size, Status and Forecast 2020-2026
Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.
Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations
Market Analysis and Insights: Global Gene Editing Technology Market
In 2019, the global Gene Editing Technology market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Gene Editing Technology Scope and Market Size
Gene Editing Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Editing Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Gene Editing Technology market is segmented into Homologous Recombination, Meganuclease, etc.
Segment by Application, the Gene Editing Technology market is segmented into Agriculture, Medical, Other, etc.
Regional and Country-level Analysis
The Gene Editing Technology market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gene Editing Technology market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Gene Editing Technology market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Gene Editing Technology business, the date to enter into the Gene Editing Technology market, Gene Editing Technology product introduction, recent developments, etc.
The major vendors include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, GE Healthcare, Editas Medicine, Agilent Technologies, QIAGEN NV, etc.
This report focuses on the global Gene Editing Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Editing Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Homologous Recombination
Meganuclease
Agriculture
Medical
Other
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Gene Editing Technology status, future forecast, growth opportunity, key market and key players.
To present the Gene Editing Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Gene Editing Technology are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations
Market Analysis and Insights: Global Gene Editing Technology Market
In 2019, the global Gene Editing Technology market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Gene Editing Technology Scope and Market Size
Gene Editing Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Editing Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Gene Editing Technology market is segmented into Homologous Recombination, Meganuclease, etc.
Segment by Application, the Gene Editing Technology market is segmented into Agriculture, Medical, Other, etc.
Regional and Country-level Analysis
The Gene Editing Technology market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gene Editing Technology market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Gene Editing Technology Market Share AnalysisGene Editing Technology market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Gene Editing Technology business, the date to enter into the Gene Editing Technology market, Gene Editing Technology product introduction, recent developments, etc.
The major vendors include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, GE Healthcare, Editas Medicine, Agilent Technologies, QIAGEN NV, etc.
This report focuses on the global Gene Editing Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Editing Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Market segment by Type, the product can be split into
Homologous Recombination
Meganuclease
Market segment by Application, split into
Agriculture
Medical
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gene Editing Technology status, future forecast, growth opportunity, key market and key players.
To present the Gene Editing Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Gene Editing Technology are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
